Key facts
| Price (PPV) | 71.50 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | enalaprilhydrochlorothiazide |
| Class | Agents acting on the renin-angiotensin system |
| ATC code | C09BA02 |
| Manufacturer | ZENITH PHARMA |
| Presentation | Boite de 30 |
| Hospital price | 44.70 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement de l'hypertension artérielle en cas d'échec thérapeutique d'une monothérapie par un inhibiteur de l'enzyme de conversion.
Find an open pharmacy
On-call pharmacies near you
About Co-Iprel 20 mg / 12.5 mg
Co-Iprel 20 mg / 12.5 mg belongs to the agents acting on the renin-angiotensin system therapeutic class. In Morocco, this drug is marketed by ZENITH PHARMA and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Co-Iprel 20 mg / 12.5 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Co-Iprel 20 mg / 12.5 mg
Answers to common questions from Moroccan patients about this drug.